Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Therapeutic Advances in Infectious Disease is Scopus-indexed (Q2, CiteScore 5.3), WoS ESCI, DOAJ. Published by SAGE Publications Inc..
Checked against the index lists dated .
ISSN 2049-9361Verify ISSN ↗2049-937XVerify ISSN ↗
Publisher: SAGE Publications Inc.
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Infectious Diseases | 111 / 361 | 69th | Q2 |
| Pharmacology (medical) | 89 / 278 | 68th | Q2 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2013–present, best quartile Q2, CiteScore 5.3.
Therapeutic Advances in Infectious Disease is Q2 in Infectious Diseases (rank 111 of 361) and Q2 in Pharmacology (medical) (rank 89 of 278), by CiteScore 2025.
Therapeutic Advances in Infectious Disease is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 5.3, which places it in quartile Q2 at the 69th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.948, quartile Q2, with an H-index of 38.
The publisher lists an article processing charge of about US$2,800 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Therapeutic Advances in Infectious Disease is published by SAGE Publications Inc. Its print ISSN is 2049-9361 and its online ISSN is 2049-937X.
Yes — indexed in the Emerging Sources Citation Index.
Yes — it is an open-access journal, listed in DOAJ.
Therapeutic Advances in Infectious Disease has an h-index of 44 and a 2-year mean of 2.45 citations per paper (OpenAlex). Its Scopus CiteScore is 5.3, quartile Q2. On 2-year citations it ranks #133 of 354 Scopus journals in Infectious Diseases.
Therapeutic Advances in Infectious Disease published 105 papers in 2025. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 98 research articles (2025–2026), authors are most often from United States (22.1%), Ethiopia (9.2%) and Uganda (6.9%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 2 retracted papers are recorded (3.1 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.